Trials / Not Yet Recruiting
Not Yet RecruitingNCT07237711
Clinical Investigation of Sensovisc
Clinical Investigation of Sensovisc Sterile Sodium Hyaluronate Gel in the Knee Joint
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (estimated)
- Sponsor
- Ankara City Hospital Bilkent · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical investigation aims to investigate the safety and performance of Sensovisc. Sensovisc is used to reduce osteoarthritis (OA) related pain in the joints by supporting synovial fluid by intra-articular injection and allowing the synovial fluid to restore its viscoelastic properties. It increases the joint mobility by reducing or eliminating the pain. This Clinical Investigation was designed as a cross-sectional, interventional, and prospective study.
Detailed description
Osteoarthritis (OA) is the most prevalent chronic arthritis and a leading cause of pain and disability among adults. OA is a degenerative joint disease characterized by chronic inflammation, cartilage degradation and erosion of underlying bone in the affected joints, predominantly affects knees, significantly impacting patient mobility and quality of life. * Although there are currently no approved disease-modifying osteoarthritis drugs (DMOADs), nonpharmacologic interventions, such as physical therapy and weight management, and pharmaceutical approaches are available to reduce or revise joint damage and inflammation. * Among various therapeutic interventions, intra-articular hyaluronic acid (HA) injections have emerged as an alternative promising treatment. Emerging evidence suggests that HA may exert chondroprotective effects by enhancing synovial fluid viscosity, improving joint lubrication, and mitigating inflammatory processes, thereby potentially decelerating disease progression and preserving cartilage integrity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sensovisc® | Injectable Sterile Sodium Hyaluronate Gel |
Timeline
- Start date
- 2025-11-25
- Primary completion
- 2026-08-25
- Completion
- 2026-11-25
- First posted
- 2025-11-20
- Last updated
- 2025-11-20
Source: ClinicalTrials.gov record NCT07237711. Inclusion in this directory is not an endorsement.